EUVIMEDEUVIMED entdecken
Crossref

Effect of Acridine Orange and Zoledronic Acid on Bone Metastasis in Renal Cell Carcinoma

Keita Oya, Hiroyuki Tsuchie, Hiroyuki Nagasawa, Michio Hongo, Yuji Kasukawa, Daisuke Kudo, Ryo Shoji, Fumihito Kasama, Takashi Kawaragi, Manabu Watanabe, Kenta Tominaga, Naohisa Miyakoshi

Anticancer Research · 2024

DOI: 10.21873/anticanres.17055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Keita Oya und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan; koya@med.akita-u.ac.jp. Hauptthemen laut MEDLINE: Zoledronic Acid, Carcinoma, Renal Cell, Bone Neoplasms, Kidney Neoplasms.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: The increasing incidence of renal cell carcinoma (RCC) and its associated bone metastasis pose challenges in surgical interventions, warranting the exploration of novel therapeutic approaches. Therefore, this study aimed to assess the impact of hematogenously administering acridine orange (AO) alone and in combination with zoledronic acid (ZA) on bone metastasis in RCC. MATERIALS AND METHODS: RENCA cells (1.0×106 cells/10 μl) were directly injected into the right femur of male BALB/c mice. The mice were categorized into four groups based on the applied therapeutic intervention and were euthanized after five weeks. Micro-computed tomography was performed to quantify the extent of periosteal reaction, indicative of bone metastasis, along the entire length of the femur. Tumor weight and volume were measured at euthanization. Hematoxylin and eosin staining was used to examine the extent of tumor development in the bone. Apoptotic cell, osteoclast, and vascular endothelial growth factor (VEGF)-positive cell counts were assessed using TdT-mediated dUTP-biotin nick end labeling, tartrate-resistant acid phosphatase staining, and VEGF staining, respectively. RESULTS: The periosteal reaction was significantly reduced in the intervention groups compared to the control group (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zoledronic AcidCarcinoma, Renal CellBone NeoplasmsKidney NeoplasmsAcridine OrangeMice, Inbred BALB CApoptosisAnimalsMaleMiceCell Line, TumorHumansVascular Endothelial Growth Factor AImidazolesX-Ray MicrotomographyXenograft Model Antitumor Assays

Stichwörter der Autor:innen

Renal cell carcinomaacridine orangebone metastasiszoledronic acid

Substanzen

Zoledronic AcidAcridine OrangeVascular Endothelial Growth Factor AImidazoles

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan; koya@med.akita-u.ac.jp.
  • Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
  • Department of Orthopedic Surgery, Akita Kousei Medical Center, Akita, Japan.
  • Department of Orthopedic Surgery, Yuri Kumiai General Hospital, Akita, Japan.

Zitieren

APA

Oya, K., Tsuchie, H., Nagasawa, H., Hongo, M., Kasukawa, Y., Kudo, D., Shoji, R., Kasama, F., Kawaragi, T., Watanabe, M., Tominaga, K., & Miyakoshi, N. (2024). Effect of Acridine Orange and Zoledronic Acid on Bone Metastasis in Renal Cell Carcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.17055

Vancouver

Oya K, Tsuchie H, Nagasawa H, Hongo M, Kasukawa Y, Kudo D, et al. Effect of Acridine Orange and Zoledronic Acid on Bone Metastasis in Renal Cell Carcinoma. Anticancer Research. 2024. doi:10.21873/anticanres.17055

BibTeX
@article{Oya2024,
  author = {Oya, Keita and Tsuchie, Hiroyuki and Nagasawa, Hiroyuki and Hongo, Michio and Kasukawa, Yuji and Kudo, Daisuke and Shoji, Ryo and Kasama, Fumihito and Kawaragi, Takashi and Watanabe, Manabu and Tominaga, Kenta and Miyakoshi, Naohisa},
  title = {Effect of Acridine Orange and Zoledronic Acid on Bone Metastasis in Renal Cell Carcinoma},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17055}
}
Kostenlos starten →